Journal:JBSD:36
From Proteopedia
(Difference between revisions)

Line 4: | Line 4: | ||
<hr/> | <hr/> | ||
<b>Molecular Tour</b><br> | <b>Molecular Tour</b><br> | ||
- | The current study reports on the apo crystal structure of the <scene name='Journal:JBSD:36/Cv/3'>South African HIV-1 subtype C protease (C-SA PR)</scene>. Structure of <scene name='Journal:JBSD:36/Cv/4'>unbound HIV-1 PR</scene> with the active site triplet (D25, T26 and G27) shown in ball-and-stick representation, <font color='magenta'><b>hinge region in magenta (residues 35–42 and 57–61)</b></font>, and <span style="color:cyan;background-color:black;font-weight:bold;">flap region (residues 46–54) in cyan</span>. The relevance of this study cannot be underestimated because South Africa is at the epicenter of the HIV/AIDS pandemic. A detailed understanding of the molecular interactions between the drug and its target is required if we are to improve the design of protease inhibitors (PIs). Our study indicated that the loss of a salt bridge between <scene name='Journal:JBSD:36/Cv/5'>residues E35 and R57</scene> at the hinge region affects the flap dynamics of the apo C-SA PR which may reduce the affinity and, therefore, the efficacy of the current protease inhibitors toward the C-SA PR. The crystal structure of the C-SA PR will serve as a foundation to improve the rational design of PIs which will have a greater impact on anti-retroviral chemotherapy in sub-Saharan Africa. | + | The current study reports on the apo crystal structure of the <scene name='Journal:JBSD:36/Cv/3'>South African HIV-1 subtype C protease (C-SA PR)</scene>. Structure of <scene name='Journal:JBSD:36/Cv/4'>unbound HIV-1 PR</scene> with the active site triplet (D25, T26 and G27) shown in ball-and-stick representation, <font color='magenta'><b>hinge region in magenta (residues 35–42 and 57–61)</b></font>, and <span style="color:cyan;background-color:black;font-weight:bold;">flap region (residues 46–54) in cyan</span>. The relevance of this study cannot be underestimated because South Africa is at the epicenter of the HIV/AIDS pandemic. A detailed understanding of the molecular interactions between the drug and its target is required if we are to improve the design of protease inhibitors (PIs). Our study indicated that the loss of a salt bridge between <scene name='Journal:JBSD:36/Cv/5'>residues E35 and R57</scene> at the hinge region affects the flap dynamics of the apo C-SA PR which may reduce the affinity and, therefore, the efficacy of the current protease inhibitors toward the C-SA PR (<span style="color:deeppink;background-color:black;font-weight:bold;">subtype C-SA PR is in deeppink</span>, [[3u71]] and <span style="color:yellow;background-color:black;font-weight:bold;">subtype B PR is in yellow</span>, [[2pc0]]). The crystal structure of the C-SA PR will serve as a foundation to improve the rational design of PIs which will have a greater impact on anti-retroviral chemotherapy in sub-Saharan Africa. |
</StructureSection> | </StructureSection> | ||
<references/> | <references/> | ||
__NOEDITSECTION__ | __NOEDITSECTION__ |
Revision as of 12:28, 9 October 2012
|
- ↑ REF
This page complements a publication in scientific journals and is one of the Proteopedia's Interactive 3D Complement pages. For aditional details please see I3DC.